Eplivanserin inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets 5-HT2A receptor, 5-HT2A receptor, and 5-HT2C receptor.
Molecular Weight
328.38
Molecular Formula
C19H21FN2O2
Targets
5-HT2A receptor: 5.8 nM (IC50, in rat cortical membrane); 5-HT2A receptor: 1.14 nM; 5-HT2C receptor: 120 nM
Form
Lyophilized powder
Purity
>98%
Applications
Eplivanserin can be used for its ability to promote sleep induction and improve sleep quality in patients with insomnia.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.